2 results
Categories
Human Remove Human filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Accelerated assessment Remove Accelerated assessment filter
Medicine
Referrals Remove Referrals filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Referral safety status
Yes Remove Yes filter
Referral PRAC recommendation
Risk minimisation measures Remove Risk minimisation measures filter
-
List item
Referral: Xeljanz
tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020 -
List item
Referral: Lemtrada
alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020